2011Journal of Practical DermatologyRequires access

Clinial eff icacy of 0.03% tacrolimus ointment for atopic blepharitis

Wu Jian-hua

Open publisher page 0 citations

Abstract

Objective To investigate the clinical efficacy of 0.03% tacrolimus ointment in patients with atopic blepharitis.Methods Twenty-six patients were treated with 0.03% tacrolimus ointment twice a day for 2 weeks,and the clinical symptom and sign scores were recorded before and after treatment.Results The clinical cured rate was 57.69%,76.94%,92.30% and 73.08% at the 3th day,7th day,14th day and 30th day after treatment respectively.Among a variety of skin lesions,the therapeutic effect was better for erythema and itching than that for xerosis cutis and thickening.Four cases(15.38%) were reported to have local burning,which all happened in the first 3 days of treatment.There are 7(26.92%) patients who recurrent after withdraw of the treatment.Conclusion 0.03% tacrolimus ointment is an effective treatment option for the patients with atopic blepharitis.Long-term efficacy and safety of the medicine have to be evaluated by long-term follow-up studies.

About this research paper

What this paper is about

Objective To investigate the clinical efficacy of 0.03% tacrolimus ointment in patients with atopic blepharitis.Methods Twenty-six patients were treated with 0.03% tacrolimus ointment twice a day for 2 weeks,and the clinical symptom and sign scores were recorded before and after treatment.Results The clinical cured rate was 57.69%,76.94%,92.30% and 73.08% at the 3th day,7th day,14th day and 30th day after treatment respectively.Among a variety of skin lesions,the therapeutic effect was better for erythema and itching than that for xerosis cutis and thickening.Four cases(15.38%) were reported to have local burning,which all happened in the first 3 days of treatment.There are 7(26.92%) patients who recurrent after withdraw of the treatment.Conclusion 0.03% tacrolimus ointment is an effective treatment option for the patients with atopic blepharitis.Long-term efficacy and safety of the medicine have to be evaluated by long-term follow-up studies.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical efficacy of 0.03% tacrolimus ointment in patients with atopic blepharitis.Methods Twenty-six patients were treated with 0.03% tacrolimus ointment twice a day for 2 weeks,and the clinical symptom and sign scores were recorded before and after treatment.Results The clinical cured rate was 57.69%,76.94%,92.30% and 73.08% at the 3th day,7th day,14th day and 30th day after treatment respectively.Among a variety of skin lesions,the therapeutic effect was better for erythema and itching than that for xerosis cutis and thickening.Four cases(15.38%) were reported to have local burning,which all happened in the first 3 days of treatment.There are 7(26.92%) patients who recurrent after withdraw of the treatment.Conclusion 0.03% tacrolimus ointment is an effective treatment option for the patients with atopic blepharitis.Long-term efficacy and safety of the medicine have to be evaluated by long-term follow-up studies.

Key concepts: Medicine, Tacrolimus, Itching, Dermatology, Erythema, Blepharitis, Atopic dermatitis, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinial eff icacy of 0.03% tacrolimus ointment for atopic blepharitis — Research Paper | ScholarLens